Bettinger T, Remy J S, Erbacher P
Laboratoire de Chimie Génétique, Faculté de Pharmacie, CNRS (UMR 7514) et Université Louis Pasteur de Strasbourg, BP 24, F-67401 Illkirch Cedex, France.
Bioconjug Chem. 1999 Jul-Aug;10(4):558-61. doi: 10.1021/bc990006h.
Hepatocytes are interesting targets for gene therapy applications. Several hepatocyte-directed gene delivery vectors have been described. For example, simple galactosyl residues coupled to polyethylenimine (PEI) gave an efficient vector which selectively transfected hepatocytes via the asialoglycoprotein receptor-mediated endocytosis [Zanta, M. A., et al. (1997) Bioconjugate Chem. 8, 839-844]. However, the large size of these galactosylated PEI/DNA complexes prevented their use in vivo. We have investigated the role of the saccharide length on the size of glycosylated-PEI/DNA particles. When 5% of the PEI nitrogens were grafted with a linear tetragalactose structure (lGal4), small and stable particles were formed upon complexation with plasmid DNA. These particles were essentially toroids having a size of 50-80 nm and a zeta-potential close to neutrality. Moreover, these slightly charged PEI-lGal4/DNA complexes were as selective as the previously described galactosylated-PEI vector to transfect hepatocytes, but in addition, they were more efficient. It is expected that the properties of the PEI-lGal4/DNA complexes may increase their diffusion into the liver and their efficiency to transfect hepatocytes.
肝细胞是基因治疗应用中有趣的靶点。已经描述了几种肝细胞靶向基因递送载体。例如,与聚乙烯亚胺(PEI)偶联的简单半乳糖基残基产生了一种有效的载体,该载体通过去唾液酸糖蛋白受体介导的内吞作用选择性地转染肝细胞[赞塔,M.A.等人(1997年)《生物共轭化学》8卷,839 - 844页]。然而,这些半乳糖基化的PEI/DNA复合物的大尺寸阻碍了它们在体内的应用。我们研究了糖链长度对糖基化-PEI/DNA颗粒大小的作用。当5%的PEI氮原子接枝线性四糖结构(lGal4)时,与质粒DNA复合后形成小而稳定的颗粒。这些颗粒基本上是尺寸为50 - 80纳米且ζ电位接近中性的环形。此外,这些带轻微电荷的PEI-lGal4/DNA复合物在转染肝细胞方面与先前描述的半乳糖基化-PEI载体一样具有选择性,但除此之外,它们更有效。预计PEI-lGal4/DNA复合物的特性可能会增加它们在肝脏中的扩散以及转染肝细胞的效率。